Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
01-Feb-2026 | 1,889 | 1,925.6 | 1,876.8 | 1,898.5 | 5,158 | 8,26,16,813.3 | 19,204 |
02-Feb-2026 | 1,904.8 | 1,919.8 | 1,839 | 1,906.9 | 7,390 | 4,91,57,847.1 | 10,731 |
03-Feb-2026 | 1,941 | 1,941 | 1,876.1 | 1,904.3 | 7,610 | 7,97,91,694.4 | 21,169 |
04-Feb-2026 | 1,900 | 1,918.3 | 1,855 | 1,896 | 7,124 | 7,91,89,260.5 | 15,337 |
05-Feb-2026 | 1,924.5 | 2,044 | 1,909 | 1,972.5 | 30,927 | 80,86,53,308 | 43,650 |
06-Feb-2026 | 1,974 | 2,027.4 | 1,962.1 | 1,986.9 | 11,303 | 16,85,79,560.1 | 25,434 |
09-Feb-2026 | 2,007.5 | 2,015 | 1,970.1 | 1,999.4 | 10,042 | 8,49,18,684.1 | 21,591 |
10-Feb-2026 | 2,000 | 2,015 | 1,990.1 | 2,005.6 | 3,446 | 3,06,43,958.1 | 8,564 |
11-Feb-2026 | 1,995 | 2,011.8 | 1,987.7 | 1,999 | 2,894 | 2,44,21,032.7 | 6,097 |
12-Feb-2026 | 1,990 | 2,005 | 1,973.3 | 1,987.4 | 4,208 | 4,15,13,965.5 | 11,275 |
13-Feb-2026 | 1,977.6 | 1,980.6 | 1,934.1 | 1,947.8 | 4,345 | 7,80,77,824.2 | 23,332 |
16-Feb-2026 | 1,961.5 | 1,963.3 | 1,918.1 | 1,937.6 | 2,955 | 4,04,11,195 | 10,212 |
17-Feb-2026 | 1,936 | 1,948.9 | 1,923.8 | 1,929.2 | 2,066 | 1,62,65,026.2 | 4,670 |
18-Feb-2026 | 1,932.5 | 1,940 | 1,911 | 1,928 | 1,960 | 1,57,74,763.3 | 4,662 |
19-Feb-2026 | 1,928 | 1,939.9 | 1,890.6 | 1,899.4 | 2,172 | 1,92,95,717.1 | 5,390 |
20-Feb-2026 | 1,905 | 1,905.1 | 1,853.6 | 1,860.1 | 4,633 | 4,76,44,827.3 | 16,503 |
23-Feb-2026 | 1,876.5 | 1,959.9 | 1,864.8 | 1,941.6 | 6,760 | 10,75,50,958.2 | 17,793 |
24-Feb-2026 | 1,937.1 | 1,937.1 | 1,880.6 | 1,894.6 | 4,884 | 5,51,62,132.9 | 10,607 |
25-Feb-2026 | 1,900 | 1,910.5 | 1,880 | 1,886.4 | 2,787 | 2,57,44,781.5 | 7,869 |
26-Feb-2026 | 1,886.4 | 1,899.5 | 1,871.1 | 1,890.5 | 2,129 | 2,04,70,643.3 | 4,280 |
27-Feb-2026 | 1,889.9 | 1,929.8 | 1,856.5 | 1,903.8 | 2,671 | 3,77,68,295.7 | 14,054 |
Metropolis Healthcare said it plans to expand its genomic test portfolio to more than 500 advanced tests over the next two to three years
The deal includes a deferred payment of ₹1.7 crore, which will be disbursed as per the terms of the business transfer agreement, the company said in a regulatory filing.
The EBITDA margin fell to 18% in Q4 FY25 from 24.2% in Q4 FY24, reflecting a fall in operational efficiency or profitability.
The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.
This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.
Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.
Here are some of the stocks that may see significant price movement today: Titan Company, HDFC Bank, IndusInd Bank, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
